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Abstract 
Influenza virus binds to cell surface sialic acid receptors, and following endocytosis fuses with the endosome membrane at low pH. 
Whether sialic acid plays a role in the virus-cell membrane fusion step is not known. We investigated the effect of the removal of cell 
membrane sialic acid on the fusion activity of influenza virus (A /PR/8 /34  strain) toward human T lymphocytic leukemia (CEM) cells 
at low pH. Fusion was monitored by fluorescence dequenching of octadecylrhodamine incorporated in the virus membrane. Removal of 
sialic acid by neuraminidase resulted in a drastic reduction in both viral binding and fusion. The association of the virus with 
neuraminidase-treated c lls was enhanced at pH 5, compared to that at neutral pH, probably due to the unfolding of the hemagglutinin a d 
the resulting increase in viral surface hydrophobicity, but the fusion capacity of the virus was reduced significantly. The results were 
analysed with a mass-action kinetic model which could explain and predict he kinetics of fusion. Our results indicate that binding of 
influenza virus to sialic acid residues on the cell surface leads to rapid and extensive fusion and partially inhibits the low pH-induced viral 
inactivation. 
Keywords: Influenza virus; Sialic acid; Membrane fusion; Membrane binding; CEM cell; Neuraminidase; Fluorescence 
1. Introduction 
Cell surface sialic acid residues are considered to be the 
primary receptors for influenza virus [ 1-4]. Initial binding 
of the virus is followed by endocytosis, and fusion of the 
viral membrane with the endosomal membrane upon acid- 
ification of the endosome lumen [5-7]. Structural studies 
of the influenza hemagglutinin have shown sialic acid as 
the main component of the cellular receptor for the virus 
[8]. An indirect role for sialic acid in helping sialoglyco- 
proteins attain a critical structure has also been proposed 
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[9]. Whether the cell membrane sialic acid is also involved 
in the membrane fusion reaction is not known. Previous 
studies on the fusion of influenza virus with liposomes 
have indicated that the presence of ganglioside Go1 a in- 
creases the rate constant of adhesion, but not that of fusion 
[10], while studies utilizing liposomes containing varying 
amounts of gangliosides have shown an optimal surface 
concentration for virus-liposome fusion [11]. It has been 
suggested that the interaction of gangliosides GT1 b or Grab 
with influenza virus hemagglutinin causes an increase in 
the fluidity of the viral envelope, thereby promoting fusion 
with target membranes [12]. We previously examined the 
low pH-induced fusion of influenza virus with the plasma 
membranes of living CEM cells as a model to study the 
fusion of the virus with endosome membranes [13]. Here 
we have utilized this model system to investigate the role 
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of cell membrane sialic acid in the fusion reaction of 
influenza virus with cellular membranes. 
protein concentration of the labeled virus was determined 
by the Lowry assay. 
2. Materials and methods 
2.1. Materials 
Influenza virus, A /PR/8 /34  (H1NI) strain was ob- 
tained from SPAFAS (Preston, CT). The virus was grown 
for 48 h at 37°C in the allantoic cavity of 11-day-old 
specific pathogen-free embryonated eggs, purified by dis- 
continuous sucrose density gradient centrifugation and 
stored at -70°C in phosphate buffered saline. Trypsin, 
trypsin inhibitor, neuraminidase (from Vibrio cholerae, 1 
unit/ml specific activity), endoglycosidase H (1 unit/ml 
specific activity) and octaethyleneglycol dodecyl ether 
(C~2E 8) were purchased from Calbiochem (San Diego, 
CA). Tes buffer and NaC1 were from Sigma (St. Louis, 
MO). Proteinase K was obtained from Boehringer-Mann- 
heim, endoglycosidase F (200 units/ml specific activity) 
from Oxford GlycoSystems (Rosedale, NY), and octade- 
cylrhodamine B chloride (R18) from Molecular Probes 
(Eugene, OR). 
2.2. Cells 
CEM cells (obtained from the UCSF Cell Culture Facil- 
ity) were maintained in RPMI 1640 medium containing 25 
mM Hepes buffer, supplemented with 10% foetal bovine 
serum (FBS) and antibiotics. The cells were grown in T-75 
flasks under a 5% CO 2 atmosphere at 37°C up to a cell 
density of 1. 106-1.5 • 106/ml. The cells were harvested 
by centrifugation at 180 X g for 8 min at room tempera- 
ture, washed twice in Dulbecco's PBS, and once in phenol 
red-free RPMI 1640 containing 25 mM Hepes buffer (pH 
7.4) (Medium A). The cells were resuspended in the latter 
buffer at a stock cell density of 108/ml and kept on ice in 
polypropylene c ntrifuge tubes until use the same day. Cell 
viability was determined by Trypan blue exclusion and 
was routinely above 95%. 
2.3. Virus labeling 
The virus was labeled with R18 as described previously 
[14]. A 4.8 /zl aliquot of a 3.12 /xmol/ml ethanolic 
fluorophore solution was injected under vortex mixing into 
a viral suspension containing 2 mg of viral protein/ml. 
The final concentration of added probe corresponded to 
approx. 4 mol% of total viral lipid, and that of ethanol was 
less than 1% (v/v).  The mixture was incubated in the dark 
for 0.5-1 h at room temperature. R18-1abeled virus was 
separated from uninserted fluorophore by chromatography 
on Sephadex G-75 (Pharmacia, Uppsala, Sweden) using 10 
mM Tes, 150 mM NaCl (pH 7.4) as elution buffer. The 
2.4. Fusion of  R18 labeled influenza virus with CEM cells 
Fusion was monitored continuously with the RI8 fluo- 
rescence assay [13-16]. Fusion was initiated either by 
rapid injection of R18-1abeled virus (4 /~g viral protein) 
into a cuvette containing the cell suspension (4.107 cells) 
at pH 5, or by lowering the pH (to 5) of the suspension of 
cells and virus preincubated at pH 7.4. The final incuba- 
tion volume was always 2 ml Medium A and the pH was 
measured at the end of each experiment with a Beckman 
pH meter. The fluorescence scale was calibrated such that 
the initial fluorescence of the R18-1abeled virus and cell 
suspension was set at 0% fluorescence. The value obtained 
by lysing the virus and cellular membranes after each 
experiment with C I2E8 (at a final concentration of 2 mM), 
was set to 100% fluorescence. Fluorescence measurements 
were performed in a Spex Fluorolog 2 fluorometer using 
the front-face configuration in the emission channel, with 
excitation at 560 nm and emission at 590 nm, using 5 and 
25 mm slits in both monochromators. A high-pass filter 
(50% transmission at 590 nm; Schott Glass OG590, 
Melles-Griot) was placed between the cuvette and the 
emission monochromator. The sample chamber was 
equipped with a magnetic stirring device and the tempera- 
ture was controlled with a thermostatted circulating water 
bath. Some experiments were also carried out using a 
Perkin-Elmer LS-5B fluorometer, operated with a Soft- 
ways (Moreno Valley, CA) computer program. 
2.5. Binding and cell association 
Fluorescently abeled influenza virus was incubated with 
CEM cells in identical amounts as in the fusion experi- 
ments, in a final volume of 2 ml Medium A, either for 5 
min at 37°C or for 30 min at 0°C with stirring. Cell 
association experiments were carried out in the same way 
but at pH 5, with or without virus-cell prebinding at pH 
7.4. Incubations were carried out either at 37°C or 0°C 
and for 1 min or 5 min at pH 5, as described under 
Results. The cells were sedimented by centrifugation at 
4 °C for 7 rain at 180 X g and the fluorescence was 
measured at 37°C in the supernatant and pellet following 
detergent lysis. In some experiments the virus was pre- 
centrifuged at 180 X g for 7 rain to eliminate any aggre- 
gated virions, and exclude the possibility of virus co-pellet- 
ing with the cells. 
2.6. Enzymatic treatment 
CEM cells (4. 10 7) were incubated with the various 
enzymes, trypsin (0.0025% (w/v),  0.05%, and 0.1%), 
proteinase K (0.01% (w/v)  and 0.05%), neuraminidase 
(0.005 and 0.05 unit/ml), endoglycosidase H (0.005 
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uni t /ml)  and endoglycosidase F (1 un i t /ml)  in a final 
volume of 2 ml Medium A at 37 ° C for 20 min. Following 
enzymatic treatment, cells were placed on ice for 5 min to 
stop the reaction, except for trypsin where the reaction was 
terminated by adding a twofold molar excess of trypsin 
inhibitor. The cells were centrifuged at 4 ° C for 7 min at 
180 × g, washed once in cold Medium A, resuspended in
the same medium and kept on ice until use. Control cells 
were treated in parallel under the same conditions in 
Medium A without the enzyme. The use of either 0.005 or 
0.05 unit /m] neuraminidase produced the same effect on 
both virus binding and fusion, and higher enzyme concen- 
trations did not result in further inhibition. Cell viability 
was shown not to be affected by the enzymatic treatment 
at the enzyme concentrations used. 
2.7. Analysis of fusion kinetics 
The analysis of prebinding experiments was based on a 
slight modification of the procedure in Nir et al. [17]. The 
fraction of the virus prebound to the cells at neutral pH is 
denoted by B 1, whereas B 2 denotes the fraction of virus 
associated with the cells at the end of the incubation period 
at low pH. An expression for the fusion rate constant, f 
(s- J ) ,  that accounts for inactivation is given by 
f ( t )  =f(0) [exp( -y t )  + y2(l -exp( -y t ) ) /y ]  ( l )  
in which t is the time and y = yl + "Y2. In Eq. (1) y~ and 
3'_, represent forward and reverse rate constants of inacti- 
vation. In our analysis we set Y2 = 0. If B is constant and 
3',, = 0, the fraction of fused virus, F(t), is given by 
F( t )  = [1 -exp[ f (O) (exp( -y t )  - 1 ) /T ]B  (2) 
In the analysis of virus fusion with neuraminidase-treated 
cells, where B 2 was significantly larger than B~, we 
divided the time t into small segments and assumed a 
linear increase in B with time in Eq. (2). 
3. Resu l ts  
3.1. Dependence of influenza virus fusion activity on neur- 
aminidase pretreatment of CEM cells 
The fluorescence dequenching of R18 has been used as 
a reliable indicator of virus-cel l  fusion in numerous ys- 
tems [13,16,18-23]. We investigated the role of cell sur- 
face sialic acid residues in influenza virus fusion with 
CEM cells using this assay. The time-course of R18 
fluorescence dequenching during the incubation of in- 
fluenza virus with neuraminidase-treated and untreated 
(control) CEM cells is shown in Fig. 1. In preliminary 
experiments the toxic effects of a range of neuraminidase 
concentrations on cells were determined by Trypan blue 
exclusion. A concentration of neuraminidase was chosen 
(0.005 uni t /ml)  which was well below the toxic limit. 
Concentrations of neuraminidase 10-fold higher than the 
chosen concentration, did not cause any further inhibition 
of binding at 37 ° C, indicating that the significant sialic 
acid residues (i.e, those relevant o virus binding) had been 
removed by the lower enzyme concentration utilized in 
most of our binding and fusion studies. 
In one set of experiments, the virus was allowed to bind 
to the cells for 5 rain at 37°C (pH 7.4), and the pH was 
lowered to 5 to induce membrane fusion (Fig. 1A). Neur- 
aminidase pretreatment of the cells caused a drastic reduc- 
tion in virus fusion activity (curve b). In the other set of 
experiments, the virus was bound to the cells for 30 min at 
0°C (pH 7.4), and the unbound virus was removed from 
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Fig. I. Effect of neuraminidase pretreatment of CEM cells on influenza virus fusion activity. (A) Influenza virus (2 /.*g viral protein/ml) was added to 
4 • 10  7 control (a) or neuraminidase-treated (b) CEM cells in a final volume of 2 ml, and Rl8 dequenching was monitored for 5 rain at 37 ° C and pH 5, 
following virus-cell preincubation for5 min at 37 ° C. (B) Influenza virus (2 /zg viral protein/ml) was added to 4 • 10  7 control (c) or neuraminidase-treated 
(d) CEM cells in a final volume of 2 ml, and incubated for 30 min at 0 ° C. The unbound virus was removed by centrifugation in the cold, and RI8 
dequenching was monitored for 5 min at 37 ° C and pH 5. The symbols represent the values calculated by using the mass action kinetic model for control 
( [] ) and neuraminidase-treated cells (II ). 
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conditions, the fusion activity of the bound virus was also 
inhibited significantly in enzyme pre-treated cells. In con- 
trol cells, these two experimental pproaches yielded simi- 
lar values for the initial rates of fusion, as well as for the 
extents of fusion (Fig. 1, curves a and c). In treated cells, 
however, the decrease in the initial rate and extent of 
fusion was not as dramatic when the unbound virus was 
removed (curve d). 
We examined the time-course of virus-cell fusion by a 
mass-action kinetic analysis [17]. The fusion (f) and inacti- 
vation (7) rate constants given in Table 1 resulted in fits to 
the curves in Fig. 1 shown by the squares. In the case of 
neuraminidase pretreatment of cells, the data were fit best 
by invoking a decrease in f and an increase in 7, compared 
to the control cells (Table 1). When the virus was preincu- 
bated with the cells at 37 ° C, removal of sialic acid re- 
sulted in a 5-fold reduction in f, and a similar increase in 
7. Preincubation i the cold resulted in a similar pattern. 
We also investigated how the prebinding of the virus to 
the cells at neutral pH and 37 ° C, before initiation of the 
fusion reaction, affects the extent of fusion, both for 
neuraminidase-treated an  control cells (Fig. 2). When the 
virions were prebound to the normal cells, the extent of 
fusion was higher compared to the case of no prebinding 
(Fig. 2, open bars). In contrast, for neuraminidase-treated 
cells, a slight decrease in the extent of fusion was observed 
with prebinding (striped bars). 
Enzymes other than neuraminidase that were tested did 
not affect the kinetics of virus-cell fusion, at the concen- 
trations of enzyme and incubation conditions that were 
necessary to retain cell viability (data not shown), and 
were therefore not examined further. 
3.2. Virus binding and association to untreated and neur- 
aminidase-treated cells 
To further characterize the role of sialic acid in the 
fusion activity of influenza virus, experiments on virus 
binding and association to untreated (control) and neur- 
aminidase-treated cells were performed under several ex- 
perimental conditions. Fig. 3 shows that pretreatment of
cells with neuraminidase at the same concentration as the 
fusion experiments resulted in a significant decrease in 
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Fig. 2. Effect of neuraminidase pretreatment of CEM cells on the extent 
of fusion of influenza virus, with or without viral prebinding to the cells. 
Influenza virus (2 /~g viral protein/ml) was added to 4.107 control (open 
bars) or neuraminidase-treated (striped bars) CEM cells in a final volume 
of 2 ml at 37 ° C, and the extent of R18 fluorescence dequenching was 
measured after 5 min incubation at pH 5, with or without prebinding of 
the virus to the cells. In the case of viral prebinding, the virus was 
incubated with ceils for 5 min at neutral pH before lowering the pH to 5. 
In the absence of viral prebinding, the pH of the cell suspension was 
adjusted to 5 just prior to addition of virus. Values represent means of at 
least 5 experiments 5: standard eviation. 
carried out at 0°C for 30 min, the decrease in virus 
binding due to enzymatic treatment (24% of control) was 
not as pronounced as that observed when the virus was 
allowed to bind to pretreated cells at 37 ° C for 5 min (70% 
of control). In contrast, when the cells were pretreated with 
a higher concentration of neuraminidase, a similar reduc- 
tion in binding was observed at both temperatures (Table 
2). 
In addition to determining virus binding to cells at 
neutral pH, we measured the amount of cell-associated 
virus after an initial 5 min prebinding at neutral pH and 
subsequent reduction of the pH to 5. These experiments 
measure the total amount of virus bound to or fused with 
the cell membrane, 1 min or 5 min after the reduction of 
the pH. Following a 5 min incubation at low pH, 81.8% of 
the virions became associated with the control cells, and 
61.7% were associated with neuraminidase-treated c lls 
(Fig. 4). It is interesting to note that virus association with 
Table 1 
Effect of neuraminidase pretreatment of CEM cells on fusion and inactivation rate constant of influenza virus 
Preincubation condition a Cells b Fusion rate constant, Inactivation rate constant, Lag time 
f (s - 1 ) y (s- I ) (s) 
37 ° C for 5 min Control 0.15 0.01 0 
NA-treated 0.03 0.05 0 
0 ° C for 30 min, unbound virus removed Control 0.13 0.02 0.7 
NA-treated 0.033 0.058 0 
a In each case, influenza virus was preincubated with the indicated cells as described, and the pH was subsequently lowered to 5, at 37 ° C, to induce 
fusion. 
b CEM cells were either treated with 0.005 unit/ml neuraminidase (NA), as described in Section 2, or mock-treated with buffer. 
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Fig. 3. Effect of neuraminidase pretreatment of CEM cells on influenza 
virus-cell binding. Influenza virus (2 /zg viral protein/ml) was added to 
4.107 control (shaded bars) or neuraminidase-treated CEM cells (striped 
bars) in a final volume of 2 ml at pH 7.4, and incubated at 37 ° C (5 rain) 
or at 0 ° C (30 min). Virus-cell binding was determined from fluorescence 
values in the pellet and supernatant, after addition of C ~2 Es to dequench 
the RI 8 (see Section 2). Values represent means of at least 5 experiments 
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Fig. 4. Effect of neuraminidase pretreatment of CEM cells on influenza 
virus-cell association at low pH. Influenza virus (2 p~g viral protein/ml) 
was added to 4.107 control (threaded bar) or neuraminidase treated CEM 
cells (shaded bars) in a final volume of 2 ml at 37 °C. After 5 min 
incubation at pH 7.4, the virus-cell suspension was acidified to pH 5 and 
further incubated for 1 or 5 min. The fraction of cell-associated virus was 
determined by measuring the fluorescence in the pellet and the super- 
natant, after addition of CI2E 8 to dequench the RI8 (see Section 2). 
Values represent means of at least 5 experiments + standard eviation. 
the neuraminidase-treated cells was much larger than that 
expected from fusion and binding results (compare with 
Figs. 1-3). The results in Fig. 4 also indicate that v i rus-ce l l  
association after a 1 min incubation at pH 5 was 87% of 
that obtained after a 5 min incubation for control cells, and 
67% for neuraminidase-treated cells. The time course of 
cell association closely reflected the kinetics of  virus fu- 
sion with control cells, where most of  the fusion process 
was completed after 1 min. For neuraminidase-treated 
cells, however,  the amount of  virus that was cell-associ- 
ated at pH 5 exhibited a time dependence that did not 
Table 2 
Influenza virus binding to CEM cells: effects of temperature and neur- 
aminidase concentration 
Preincubation Incubation Binding b 
conditions a temperature (° C) (% fluorescence) 
Control 0 84.5 [3.1 ]
37 77.8 [0.5] 
NA (0.05 unit/ml) 0 37.7 [2.0] 
37 36.6 [1.0] 
NA (0.005 unit/ml) 0 62.9 [0.9] 
37 39.4 [1.8] 
a CEM cells were treated with either 0.05 or 0.005 unit (U)/ml neu- 
raminidase (NA), as described in Section 2, or mock-treated with buffer 
(control). 
b Influenza virus (pre-centrifuged at 180× g) was added to 4- 107 control 
or neuraminidase-treated CEM cells, at a concentration of 2 p,g viral 
protein/ml in a final volume of 2 ml at pH 7.4, and incubated at 37 ° C (5 
min) or at 0°C (30 min). Virus-cell binding was determined from 
fluorescence values in the pellet and supernatant, after addition of CI2 E8 
to dequench the RI8 (see Section 2). The numbers represent the average 
value of duplicate determinations. The numbers in square brackets how 
the spread of the data in % of virions bound. 
correlate with the viral fusion activity under the same 
conditions (see Figs. 1 and 2). 
The observation that the percentage of cell associated 
virus at low pH (Fig. 4) closely reflected the percentage of 
fusion at 1 or 5 min (Fig. 1), indicates that most of the 
virus that had bound to the control cells underwent fusion. 
This result also indicates that virions did not merely 
co-sediment non-specif ical ly with the cells during centrif- 
ugation fol lowing a low pH treatment. I f  the virus had 
aggregated and pelleted with the cells, the percentage of 
cell-associated virus would have been much larger than the 
percentage of fused virus. Previous light scattering and 
absorbance measurements had shown that virions did not 
aggregate at neutral or low pH under the experimental 
conditions employed [10,24]. The observations that (i) 
neuraminidase treatment of  cells caused a large reduction 
of  virus binding at 37°C (Fig. 3), and that (ii) essentially 
the same binding results were obtained when the virus 
preparation was pre-centrifuged before being incubated 
with the cells (Table 2 and data not shown), indicate that 
the virus did not aggregate or sediment non-specif ical ly at 
neutral pH. 
The higher fraction of  the virus associated with neur- 
aminidase-treated cells at pH 5, compared to neutral pH, 
could be the result of  the increased hydrophobicity of  the 
viral HA at low pH [25,26]. The increased hydrophobicity 
could arise from the dissociation of  the globular heads of  
the HA trimers, or from exposure of  the hydrophobic HA2 
N-terminal fusion peptide [25,27,28]. To determine whether 
the enhanced binding of  the virus to treated cells at low pH 
could be due to the unfolding of  the globular heads, cell 
association experiments were carried out under conditions 
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where the kinetics of unfolding is very slow, i.e., at 0 ° C 
[27]. Cell association measured in the cold after a 5 min 
incubation at neutral pH, was about 3-fold higher for 
control cells than for treated cells (data not shown). How- 
ever, upon further incubation for 5 min at 0 ° C at pH 5, the 
fraction of virus bound was not significantly increased, 
both for treated and control cells (data not shown), in 
contrast o the results of virus-cell association at 37°C 
(Fig. 4). Thus, the lack of an increase in virus association 
with cells in the cold upon lowering the pH, particularly in 
the case of neuraminidase-treated c lls, is consistent with 
the lack of (or very limited) unfolding of HA at low 
temperature. Although the fusion peptide is thought o be 
at least partially exposed at low temperatures [27,28], it is 
apparently not sufficient to enhance the binding of the 
virus to the cell membrane at low pH. The binding of the 
A /PR/8 /34  strain of influenza virus to liposomes at pH 
5 was also inhibited at 4 ° C, compared to the binding at 
37 ° C, despite the partial exposure of the fusion peptide 
[281. 
4. Discussion 
Several observations indicate that cell surface sialic acid 
residues modulate the fusion activity of influenza virus, as 
well as mediating its binding to the cell surface: (i) The 
fusion of virions (at 37 ° C) prebound to neuraminidase- 
treated cells (at 0 ° C) is inhibited compared to fusion with 
control cells (Fig. lb). Under these conditions where the 
unbound virions were removed, the receptor binding step 
is bypassed, and the fluorescence dequenching provides a 
measure of the fusion of virions which were already bound 
to the cells, possibly via non-sialic acid receptors. (ii) The 
fusion rate constant is decreased significantly when the 
sialic acid receptors are removed (Table 1). (iii) Prebinding 
of the virus to cells at 37 ° C does not enhance fusion with 
cells treated with neuraminidase, in contrast to control 
cells (Fig. 2). We propose that in cells from which sialic 
acid residues have been removed, virus binding occurs at 
sites on the cell surface where fusion is unfavorable. 
Alternatively, the virus may be able to bind to fusion sites, 
but it does not exhibit the proper orientation to trigger 
fusion, thus becoming inactivated at low pH [13,17,29]. 
When the cell surface sialic acid has been removed, the 
viral neuraminidase would also be unable to dislocate the 
virion from a binding site unfavorable for fusion. The 
observation that trypsin or proteinase K treatment did not 
have a significant effect on the fusion kinetics suggests 
that the binding site for influenza virus on CEM cells may 
be gangliosides rather that glycoproteins. Although further 
studies are needed to ascertain this hypothesis, previous 
studies have also implicated gangliosides as influenza virus 
receptors [1 ]. Furthermore, gangliosides have been shown 
to act as cellular receptors for Sendai virus, a paramyxo- 
virus [30]. 
The initial kinetics of fusion with neuraminidase-pre- 
treated cells depends on the conditions of preincubation of 
the virus and the cells, being apparently slower with 
preincubation at 37°C (Fig. I A, curve b) than with prein- 
cubation at 0 ° C followed by removal of the unbound virus 
(Fig. 1B, curve d). The results in Fig. 3 indicate, however, 
that the amount of virus bound at 0°C is considerably 
greater than that at 37 ° C, thus contributing to the more 
rapid kinetics observed. Indeed, the kinetic parameters 
describing the fusion reaction in both cases turn out to be 
the same, within the estimated uncertainty (Table 1). The 
kinetic parameters obtained for both incubation conditions 
were also similar in the neuraminidase-treated cells. No lag 
times were observed except for the case of preincubation 
of control cells on ice, where a lag time of 0.7 s gave the 
best fit to the data. 
Viral fusion studies using liposomes as target mem- 
branes have shown that influenza virus fuses readily with 
lipid membranes of a variety of compositions in a pH-de- 
pendent manner [10,17,24,27,31,32]. It is interesting to 
note that although the presence of sialic acid-containing 
receptors in the liposomal membrane is not required for 
fusion of influenza virus, it enhances virus binding [10]. 
Although ganglioside GD, a had little effect on the fusion 
rate constants or on the final extents of fusion, it enhanced 
3-fold the rate constant of adhesion for influenza virus 
[10]. Our results also show that influenza virus binding is 
dramatically reduced upon pretreatment of target cells with 
neuraminidase. However, the mass action kinetic model 
shows that, in contrast o virus-liposome fusion, removal 
of sialic acid also leads to a significant decrease in the 
fusion rate constant (see Table 1). The results of Stegmann 
et al. [27] suggested that gangliosides incorporated in 
zwitterionic liposomes may enhance the formation of an 
active fusion complex, thus leading to an increase in the 
rate of the actual fusion process. Studies with influenza 
virus prebound to planar bilayers with or without ganglio- 
sides suggested that the rate of membrane fusion is en- 
hanced by the presence of gangliosides [33]. The kinetics 
of fusion pore formation in planar bilayers incubated with 
influenza virus-infected cells was also found to be affected 
by gangliosides in the target membrane [34]. Recently 
Alford et al. [11] showed that the presence of GD, a could 
promote the initial kinetics of lipid mixing between in- 
fluenza virus and large DOPC liposomes containing 2.5 or 
5 mol% GD~ a, whereas with liposomes containing 10 or 15 
tool% of the ganglioside the initial kinetics was slower. 
They also demonstrated that the presence of the ganglio- 
side in liposomes reduced significantly the low pH inacti- 
vation of the virus which was preincubated with an excess 
of liposomes at neutral pH. In our system we have only 
observed enhancement in the fusion activity of the virus 
when the cell surface sialic acid was intact, which suggests 
that the sialic acid content on the surface of control CEM 
cells is in the optimal range for influenza virus fusion. 
The results presented in Fig. 2 indicate that the extent 
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of influenza virus-cell fusion is higher when the virions 
are prebound to cellular sialylated membrane receptors, 
since the virus can start fusing immediately upon acidifica- 
tion of the medium. Our previous studies [13,17,18] have 
shown that the rate constants of inactivation (y)  at pH 5 
for the virus prebound to CEM cells and several other cell 
lines are significantly lower than the values for the un- 
bound virus, thus contributing to the enhanced extent of 
fusion in the case of prebound virus. The fact that prebind- 
ing does not enhance fusion in the case of neuraminidase- 
treated cells suggests that the presence of sialic acid 
residues on control cells is essential to confer biologically 
relevant viral fusion activity. In neuraminidase-treated cells, 
fusion may exhibit some nonspecific and nonphysiological 
nature, and, therefore, virus binding to predominantly 
non-sialic acid sites will not play an important role in the 
fusion process. In addition, virus prebound to neur- 
aminidase-treated cells may undergo more inactivation 
when the pH is lowered than virus bound to control cells. 
Our experiments on virus binding to cells at neutral pH 
(Fig. 3) stress the importance of sialic acid residues on the 
cell surface as primary receptors for influenza virus. Al- 
though the amount of binding is similar at 37 ° C and 0 ° C 
for control cells, binding is higher at 0°C for the neur- 
aminidase-treated cells. These results suggest hat the de- 
gree of reversibility in virus binding at 37°C is more 
pronounced in the treated cells than in the control cells, 
since the rate constant of dissociation is generally very 
small at low temperatures [35]. However, when cells are 
pretreated with a higher concentration of neuraminidase, 
similar levels of binding are observed at 0°C and 37°C 
(Table 2). On the other hand, pretreatment of cells with 
either the high or low concentration of neuraminidase 
resulted in similar values for virus fusion activity (data not 
shown), consistent with the similar levels of virus binding 
at 37 ° C (Table 2). It is likely that following treatment with 
the lower concentration of neuraminidase ome sialic acid 
residues remain on the cell surface, which can be removed 
by the viral neuraminidase at 37°C (but not at 0 ° C, since 
the enzyme would be expected to be inactive at this 
temperature). This in turn would cause the observed reduc- 
tion in binding to the neuraminidase-treated cells at 37 ° C, 
compared to that at 0 ° C. At 0 ° C, there would be consider- 
able binding to the remaining sialic acid receptors (Fig. 3). 
This interpretation, however, does not explain why the 
viral neuraminidase does not reduce binding to untreated 
cells. It is possible that removal of some sialic acid 
residues by the neuraminidase treatment exposes new sialic 
acid moieties usceptible to the viral neuraminidase. In an 
alternative or complementary scenario, clustering of the 
remaining sialic acid-bearing residues in the cold may 
provide favorable binding sites for the virus; the dispersal 
of these receptor sites at 37 ° C may reduce the affinity of 
the virions for the cell surface. In the case of cells treated 
with the higher concentration of neuraminidase, however, 
the virus would not be able to remove any further sialic 
acid residues at 37 ° C. Thus, the level of binding at 37 ° C 
and 0 ° C would be similar. In this case, even the clustering 
of receptors in the cold would not be sufficient o mediate 
the higher level of binding, since more of the sialic acid 
residues would have been removed. 
The extensive association of influenza virus with neur- 
aminidase-treated cells at low pH (Fig. 4), without effi- 
cient fusion (Fig. l) suggests that the virus binds non- 
specifically to treated cells under these conditions, proba- 
bly due to an increase in virus surface hydrophobicity as a 
result of the dissociation of the globular heads of HA 
trimers and protonation of acidic amino acids [25,26]. The 
observation that the fluorescence of the virus associated 
with neuraminidase-treated cells is greatly quenched, while 
that of the virus associated with control cells is essentially 
dequenched (data not shown) supports this view. The 
results of these experiments also provide evidence that the 
R18 in the viral membrane does not undergo molecular 
exchange or transfer under low pH conditions, despite 
extensive binding to the plasma membrane. If molecular 
probe transfer had occurred, the large fraction of virus 
associated with treated cells at low pH should have re- 
sulted in fluorescence dequenching. This provides upport- 
ing evidence for our previous conclusion that the increase 
of R18 fluorescence upon incubation of influenza virus 
with CEM cells at low pH was mainly due to fusion [13]. 
In summary, our results demonstrate hat the presence 
of sialic acid-containing receptors is required for both 
efficient binding and fusion of influenza virus with CEM 
cells. In cells pretreated with neuraminidase, binding of 
influenza virus at neutral pH is drastically reduced; at 
mildly acidic pH cell association is enhanced, probably 
due to an increase in virus surface hydrophobicity, but 
most of the virions do not engage in fusion. Thus, in- 
fluenza virus is only able to fuse efficiently at low pH 
without becoming significantly inactivated when it is bound 
to sialic acid-containing receptors. Therefore, it might be 
suggested that in the absence of sialic acid residues in 
target cells, the kinetics and extent of fusion of influenza 
virus are low and nonspecific due to an inefficient and 
nonspecific binding. 
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